HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Marketing (Health)

Set Alert for Marketing {Health}

Product Launches

Set Alert for Launches {Health}

Latest From Health & Launches

Dutch Firm TheOTCLab Gets EU MDR Approval For Dr. Yglo OTC Wart Device

Amsterdam-based TheOTCLab has received an EU CE mark for its new wart and verruca OTC freezing device Dr. Yglo. The firm plans to launch the product in Europe in Italy, Portugal, Estonia, Latvia, and Lithuania, and will separately look to take it further afield to the US and South Africa.

Europe Estonia

UK Product Approvals: J&J Expands Sudafed And Nicorette Offerings

The UK's MHRA has approved the Rx-to-OTC switch of J&J's Sudafed Plus nasal spray (xylometazoline hydrochloride/dexpanthenol) and given the green light for the company to add new pack sizes to its Nicorette QuickMist and QuickMist Smart Track products.

Prescription To OTC Switch Launches

Health And Wellness Weekly Trademarks Review: 2 August

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements OTC Drugs
See All

Advertising Campaigns

Set Alert for Ad Campaigns {Health}

Latest From Health & Ad Campaigns

Less Than Four Weeks Remain To Enter The OTC Marketing Awards 2022

Entries to the OTC Marketing Awards are coming in thick and fast from industry players large and small across the 15 categories. With the entry deadline fast approaching on 29 August, don't miss out on your chance to win a prestigious trophy. 

Ad Campaigns Innovation

GSK Consumer Healthcare Celebrates Pain Release With UK Panadol Campaign

GSK Consumer Healthcare wants to “bring to life the emotional transformation” that UK pain sufferers experience when released from discomfort by analgesic brands like Panadol. 

United Kingdom Health

Bayer Undresses UK Vaginal Health Stereotypes And Stigmas Via Canesten Schools Program

Bayer Consumer Health in a new campaign for UK women's intimate health brand Canesten hopes to “move imagery of real vulvas away from a sexualised depiction and into an informative, educational space to equip young people with the essential information they need to better understand their bodies as well as normalise conversations.”

United Kingdom Health
See All

Advertising Enforcement

Set Alert for Ad Complaints {Health}

Latest From Health & Ad Complaints

Responsibility For Distributors’ Claims At Root Of Supplement Direct Seller’s Advertising Review

After the DSSRC recommended that Root Wellness remove health claims from its advertising in 2021, the direct seller has not made efforts to remove the claims that its ambassadors have made on social media.

Regulation Enforcement

Sanofi Appealing Findings In Review Of Zantac 360 Doctor-Recommended Claims Challenged By J&J

French pharma disagrees with NAD finding, following review of a claims made in online and social media ads, retailers' websites and a TV commercial, that the claim “#1 doctor recommended medicine” for Zantac 360 refers to the brand and not famotidine, also used in other OTC heartburn remedies, including Pepcid.

Ad Complaints OTC Drugs

Labs' High-Performance Chromatography Results Don't Help Dakota Nutrition's Elderberry Claims

NAD’s review was shorter than it might have been because Dakota Nutrition stopped using around 30 challenged disease claims, leaving a total of eight claims made on labels, its website and online retailers’ platforms about the amount of elderberry in its products.

Advisory Committees Ad Complaints
See All